Featured Research

from universities, journals, and other organizations

Juvenile Arthritis Sufferers Reap Major Benefits From Resistance Exercise Program, Buffalo Researchers Find

Date:
November 18, 1999
Source:
University At Buffalo
Summary:
New research on the effects of exercise on juvenile arthritis indicates it is OK -- advantageous, in fact -- for these kids to be kids. Children with juvenile arthritis who took part in an eight-week individualized program of resistance exercise at the University at Buffalo significantly improved their ability to function, some by as much as 200 percent, preliminary results of the study have shown.

Second study shows improved immune response linked to exercise

BOSTON -- New research on the effects of exercise on juvenile arthritis indicates it is OK -- advantageous, in fact -- for these kids to be kids.

Children with juvenile arthritis who took part in an eight-week individualized program of resistance exercise at the University at Buffalo significantly improved their ability to function, some by as much as 200 percent, preliminary results of the study have shown. Equally important, their pain, disability and use of medications decreased significantly.

Nadine Fisher, Ed.D., UB assistant professor of occupational therapy and rehabilitation medicine, presented results of the study here today (Nov. 16, 1999) at a joint meeting of the American College of Rheumatology and the Association of Rheumatology Health Professionals.

"We expected to see a change in the disease with exercise," Fisher said, "but we didn't expect to see so much. Everybody showed tremendous physiological improvement -- better strength, endurance and even better aerobic capacity, although these exercises weren't designed for that. Everyone had less pain. Some kids showed 200-percent improvement," she said. "That's pretty exciting."

An accompanying investigation conducted by Jaya Venkatraman, Ph.D., UB associate professor of nutrition, also presented here today, revealed the cellular basis for these changes: Exercise produced a change in immune response. Juvenile arthritis is a form of rheumatoid arthritis, an autoimmune disease in which the body's immune system attacks joints and surrounding tissue.

The children who took part in the exercise program had significantly lower levels of cytokines -- proinflammatory proteins -- and higher levels of anti-inflammatory compounds in their plasma than those who did not exercise, this study showed

Fisher designed the exercise program and had shown its benefits in previous studies of elderly patients with osteoarthritis. An individualized resistance-exercise program had never been tried with children, however. In fact, Fisher said she knows of only one other study of exercise and juvenile arthritis, and that study dealt with aerobic capacity.

Fisher's study, which is half-completed, has involved 11 children with juvenile arthritis to date. Six took part in the exercise program and five served as "disease" controls. Another 13 children without arthritis served as normal controls. All were between the ages of 6 and 13.

To establish a baseline level of disability or deficit, Fisher and colleagues tested the strength and endurance of the children's quadriceps and hamstrings, speed of muscle contraction, oxygen consumption, heart rate and blood pressure, and assessed their pain, disability and general functional performance. Based on this assessment, the researchers designed a resistance program for each child randomly assigned to the exercise program.

All exercises centered on the legs and were based on resistance to avoid injury to joints. They included pressing against a stationary object and lifting and holding weights for strength and endurance. Once the children adapted to the exercises, they were asked to increase the speed of weightlifting to improve coordination and balance.

Venkatraman and colleagues collected blood from all participants at four points: before and after the initial testing, after the eight-week exercise program but before the final test, and after the final test.

Results showed that the exercisers' quadriceps' strength and endurance increased 48 percent and 32 percent, respectively; hamstring strength and endurance increased 99 percent and 59 percent respectively, and muscle-contraction speed increased 51 percent. Maximum systolic blood pressure, oxygen consumption and heart rate also increased.

In addition, functional status of the group, a measure of overall physical capability, increased by 32 percent. Pain dropped nearly by half and disability and number of medications by a quarter.

The children with juvenile arthritis who did not participate in the exercise project experienced significant decreases in hamstring strength and endurance over the eight-week period, results showed. In addition, pain rose nearly 75 percent, disability by 10 percent and use of medications by 54 percent.

Assessment of the blood samples by Venkatraman and colleagues showed higher concentrations of proinflammatory cytokines in children with juvenile arthritis than in normal controls at baseline. The resistance-exercise program produced significant decreases in cytokines and increased production of anti-inflammatory compounds, results showed.

"Showing that exercise actually helps with juvenile arthritis gives parents and children ways to manage the symptoms," Fisher said. "It also allows these kids to behave more like normal kids."

Additional researchers were Kathleen M. O'Neil, M.D., UB associate professor of clinical pediatrics, and Vylma Velazquez, M.D., pediatric fellow.

The study is funded by a grant from the National Institute on Disability and Rehabilitation Research.


Story Source:

The above story is based on materials provided by University At Buffalo. Note: Materials may be edited for content and length.


Cite This Page:

University At Buffalo. "Juvenile Arthritis Sufferers Reap Major Benefits From Resistance Exercise Program, Buffalo Researchers Find." ScienceDaily. ScienceDaily, 18 November 1999. <www.sciencedaily.com/releases/1999/11/991118074851.htm>.
University At Buffalo. (1999, November 18). Juvenile Arthritis Sufferers Reap Major Benefits From Resistance Exercise Program, Buffalo Researchers Find. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/1999/11/991118074851.htm
University At Buffalo. "Juvenile Arthritis Sufferers Reap Major Benefits From Resistance Exercise Program, Buffalo Researchers Find." ScienceDaily. www.sciencedaily.com/releases/1999/11/991118074851.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins